APA aipamena

Witkiewicz, A. K., Cox, D., & Knudsen, E. S. (2014). CDK4/6 inhibition provides a potent adjunct to Her2-targeted therapies in preclinical breast cancer models. Impact Journals LLC.

Chicago Style aipamena

Witkiewicz, Agnieszka K., Derek Cox, and Erik S. Knudsen. CDK4/6 Inhibition Provides a Potent Adjunct to Her2-targeted Therapies in Preclinical Breast Cancer Models. Impact Journals LLC, 2014.

MLA aipamena

Witkiewicz, Agnieszka K., Derek Cox, and Erik S. Knudsen. CDK4/6 Inhibition Provides a Potent Adjunct to Her2-targeted Therapies in Preclinical Breast Cancer Models. Impact Journals LLC, 2014.